The Defense Production Act of 1950, and More from CRS
A new report from the Congressional Research Service provides a detailed review of the Defense Production Act of 1950, which “confers upon the President a broad set of authorities to influence domestic industry in the interest of national defense.”
“The authorities can be used across the federal government to shape the domestic industrial base so that, when called upon, it is capable of providing essential materials and goods needed for the national defense.” But unless extended by Congress, nearly all of these presidential authorities will expire next year. See The Defense Production Act of 1950: History, Authorities, and Reauthorization, June 14, 2013.
Other new and updated CRS reports that have not been made publicly available by Congress include the following.
Reserve Component Personnel Issues: Questions and Answers, updated July 12, 2013
The New START Treaty: Central Limits and Key Provisions, updated July 12, 2013
ESEA Reauthorization Proposals in the 113th Congress: Comparison of Major Features, July 12, 2013
Broadband Loan and Grant Programs in the USDA’s Rural Utilities Service, updated July 12, 2013
Oman: Reform, Security, and U.S. Policy, July 12, 2013
Despite significant political momentum behind reform efforts, limited attention has been paid to the federal workforce that will actually be responsible for interpreting and implementing new permitting regulations and better outcomes.
Nearly 150 organizations and government officials have endorsed the call to action and solutions for extreme heat, now public at HeatAgenda.US Washington, D.C. – July 7, 2026 – As millions of Americans continue to struggle to stay cool following one of the hottest Independence Day holidays on record, the Federation of American Scientists (FAS), one […]
Addressing rising heat will take all of us. Together, we can create heat-safe homes, workplaces, schools, childcare facilities, and communities – the backbone of a heat-ready nation.
DNA synthesis and export controls remain the primary regulatory safeguards against de novo production of harmful biological agents, yet governance frameworks lack the situational awareness and enforcement capacity to keep pace with rapidly falling technical barriers.